We are a drug discovery company specialising in the development of novel therapeutics to treat patients for whom there is an unmet medical need
The CompanySentinel was founded in 2005 with the aim to develop innovative new therapies for diseases with unmet clinical needs
The Sentinel management team has broad expertise in the healthcare sector. We are supported by an experienced advisory network
The TeamWe work from concept to delivery of candidate drugs and beyond. Sentinel has developed a portfolio of new therapies and is committed to improving the treatment options for patients